Northwestern University Neuropsychologist Dr. Sandra Weintraub on Alzheimer’s and brain health


FILE – In this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal approval for a medicine to treat early Alzheimer’s disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia.
The announcement Tuesday, Oct. 22, 2019, is a surprise because the company earlier this year stopped two studies of the drug, called aducanumab, after partial results suggested it was not working. (AP Photo/Matt York, File)

Alzheimer’s is an aging disease and is a type of dementia that affects the memory, thinking, and behavior of a person. Bob Sirott was joined by Professor of Psychiatry and Behavioral Sciences at Northwestern School of Medicine, Dr. Sandra Weintraub. The two discuss Alzheimer’s and what research has found on keeping mentally active.

For more information, visit ALZ.ORG/ILLINOIS

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Bob Sirott
Weekdays 5-9am BobSirott

Bob Sirott's acclaimed broadcasting career has spanned nearly five decades and has included stints at WMAQ, WBBM-FM, WLS, WGN and various television stations. (Click for more.)